SCHEMBL20189682

SCHEMBL20189682

COc1cccc(OC)c1N/C(=N\N)c1cncs1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.46
HDAC1 Q13547 1/20 0.36
ACACB O00763 1/20 0.36
CYP3A4 P08684 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
APLNR P35414 4/20 0.34
PTPN11 Q06124 1/20 0.33
MAPT P10636 2/20 0.33
GAA P10253 2/20 0.33
DYRK1A Q13627 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
AAK1 Q2M2I8 1/20 0.32
IRAK4 Q9NWZ3 1/20 0.32
NPC1 O15118 1/20 0.32
IMPDH2 P12268 1/20 0.32
IMPDH1 P20839 1/20 0.32
CHRM4 P08173 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23583951 1.00 KMT2A (0.46) KMT2AHDAC1ACACBCYP3A4TDP1
SCHEMBL20189684 1.00 KMT2A (0.46) KMT2AHDAC1ACACBCYP3A4TDP1
SCHEMBL20189524 0.80 KMT2A (0.66) KMT2AHDAC1ACACBAPLNRPTPN11
SCHEMBL20207355 0.80 KMT2A (0.49) KMT2AHDAC1ACACBAPLNRPTPN11
SCHEMBL20189397 0.80 KMT2A (0.49) KMT2AHDAC1ACACBCYP3A4APLNR
SCHEMBL20189542 0.74 GAA (0.41) KMT2ATDP1MAPTGAAKDM4E
SCHEMBL20189540 0.74 GAA (0.41) KMT2ATDP1MAPTGAAKDM4E
SCHEMBL20207359 0.74 GAA (0.41) KMT2ATDP1MAPTGAAKDM4E
SCHEMBL18927598 0.71 SMN1; SMN2 (0.41) KMT2ACYP3A4APLNRMAPTGAA
SCHEMBL23026135 0.70 APLNR (0.56) KMT2AAPLNRPTPN11KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11046680-B1 Heteroaryl-substituted triazoles as APJ receptor agonists AMGEN INC. (US) 2021-06-29 US disclosed
EP-3541805-B1 HETEROARYL-SUBSTITUTED TRIAZOLES AS APJ RECEPTOR AGONISTS AMGEN INC (US) 2020-10-14 EP disclosed
EP-3541805-A1 HETEROARYL-SUBSTITUTED TRIAZOLES AS APJ RECEPTOR AGONISTS Amgen Inc. (US) 2019-09-25 EP disclosed
WO-2018097945-A1 HETEROARYL-SUBSTITUTED TRIAZOLES AS APJ RECEPTOR AGONISTS AMGEN INC. (US) 2018-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11046680-B1 Heteroaryl-substituted triazoles as APJ receptor agonists AGTR1, AGTR2, TBXA2R KMT2A 3480/4885HDAC1 1216/4885ACACB 2774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.